Background: 
Cardiovascular disease (CVD) is a major cause of mortality in End stage renal disease (ESRD) patients on Maintenance haemodialysis (MHD). Lp (a), is a specialized form of glycoprotein-LDL-cholesterol complex and is an independent risk factor for myocardial infarction. The risk is related to its atherogenic and thrombogenic properties. The present study was taken up to evaluate changes in Lp(a) and Lipid profile in patients undergoing hemodialysis session. 

Methodology: 
Twenty seven patients with end stage renal disease who were on maintenance hemodialysis were included. Plasma samples were collected hourly during a dialysis session with polysulfone membrane using bicarbonate dialysate. Plas...
Increased plasma concentrations of LDL-unbound apo(a) in patients with end-stage renal disease. Rapi...
Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein ...
Evidence that reduced lipoprotein lipase activity is not a primary pathogenetic factor for hypertrig...
Lipoprotein(a) is a predictor for cardiovascular mortality of hemodialysis patients.BackgroundAlthou...
Lipoprotein(a) as a risk factor for coronary artery disease in hemodialysis patients.BackgroundWe st...
Mortality from cardiovascular disease in patients on chronic hemodialysis (HD) is 10 to 20 times gre...
Lipoprotein(a) (Lp(a)) consists of a low-density lipoprotein-like particle and a covalently linked h...
Lipoprotein(a) (Lp(a)) consists of a low-density lipoprotein-like particle and a covalently linked h...
Influence of dialysis on plasma lipid peroxidation products and antioxidant levels. In patients with...
Influence of hematocrit on the measurement of lipoproteins demonstrated by the example of lipoprotei...
Dyslipidemias may account for the excess of cardiovascular mortality in end-stage renal disease (ESR...
Abnormalities in lipoprotein metabolism in hemodialysis patients.BackgroundPatients on chronic hemod...
Reduced lipid concentrations during four years of dialysis with low molecular weight heparin. Hepari...
End-stage renal disease (ESRD) causes oxidative stress, inflammation, low-density lipoprotein (LDL) ...
Maintenance hemodialysis (MHD) patients experience various abnormalities such as systemic inflammati...
Increased plasma concentrations of LDL-unbound apo(a) in patients with end-stage renal disease. Rapi...
Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein ...
Evidence that reduced lipoprotein lipase activity is not a primary pathogenetic factor for hypertrig...
Lipoprotein(a) is a predictor for cardiovascular mortality of hemodialysis patients.BackgroundAlthou...
Lipoprotein(a) as a risk factor for coronary artery disease in hemodialysis patients.BackgroundWe st...
Mortality from cardiovascular disease in patients on chronic hemodialysis (HD) is 10 to 20 times gre...
Lipoprotein(a) (Lp(a)) consists of a low-density lipoprotein-like particle and a covalently linked h...
Lipoprotein(a) (Lp(a)) consists of a low-density lipoprotein-like particle and a covalently linked h...
Influence of dialysis on plasma lipid peroxidation products and antioxidant levels. In patients with...
Influence of hematocrit on the measurement of lipoproteins demonstrated by the example of lipoprotei...
Dyslipidemias may account for the excess of cardiovascular mortality in end-stage renal disease (ESR...
Abnormalities in lipoprotein metabolism in hemodialysis patients.BackgroundPatients on chronic hemod...
Reduced lipid concentrations during four years of dialysis with low molecular weight heparin. Hepari...
End-stage renal disease (ESRD) causes oxidative stress, inflammation, low-density lipoprotein (LDL) ...
Maintenance hemodialysis (MHD) patients experience various abnormalities such as systemic inflammati...
Increased plasma concentrations of LDL-unbound apo(a) in patients with end-stage renal disease. Rapi...
Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein ...
Evidence that reduced lipoprotein lipase activity is not a primary pathogenetic factor for hypertrig...